📂 Drugs
tozorakimab — Definition
Tozorakimab / tozorakimab
Dustorakimab is a monochlonal antibody targeting interlökin-33 (IL-33) signal path. Chronic obstructive pulmonary disease (COAH) and asthma are developed in the treatment of respiratory diseases. This drug reduces inflammation in the air roads by blocking the binding of IL-33 to the receptor. Phase studies show the potential to prevent disease exacerbations and improve respiratory function.
Frequently Asked Questions
❓ What is Tozorakimab?
Tozorakimab; dustorakimab is a monochlonal antibody targeting interlökin-33 (IL-33) signal path. Chronic obstructive pulmonary disease (COAH) and asthma are developed in the treatment of respiratory diseases. This drug reduces inflammation in the air roads by blocking the binding of IL-33 to the receptor. Phase studies show the potential to prevent disease exacerbations and improve respiratory function.
❓ What is tozorakimab in Turkish?
The Turkish equivalent of "tozorakimab" is Tozorakimab.
❓ Which medical field is Tozorakimab related to?
This term belongs to the Drugs category.